MGLU2 AGONISTS

The present invention provides novel mGlu2 agonists useful in the treatment of bipolar disorder, schizophrenia, depression, and generalized anxiety disorder.

Saved in:
Bibliographic Details
Main Authors MONN, JAMES ALLEN, MONTERO SALGADO, CARLOS, TABOADA MARTINEZ, LORENA, SHAW, BRUCE WILLIAM, PRIETO, LOURDES
Format Patent
LanguageCroatian
English
Published 06.12.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides novel mGlu2 agonists useful in the treatment of bipolar disorder, schizophrenia, depression, and generalized anxiety disorder.
Bibliography:Application Number: HR2013P001052T